Andrea Casadei Gardini, MD, San Raffaele Research Hospital

Articles

Future Directions for HCC Management

December 1st 2021

Drs Josep Llovet, Stephen L. Chan, and Andrea Casadei Gardini discuss the future treatment landscape for HCC.

Management of Advanced HCC Associated With NASH

December 1st 2021

Stephen L. Chan, MD, leads the discussion on the prevalence and management of advanced HCC in patients with NASH.

Treatment Options for Advanced HCC With Underlying NASH

December 1st 2021

A panel of experts in gastroenterology review the case of a 65-year-old man with advanced HCC associated with NASH and comment on treatment with TKIs and immunotherapy.

Sequencing Systemic Therapy for Advanced HCC

November 24th 2021

Andrea Casadei Gardini, MD, leads the discussion on the optimal sequencing of systemic therapy for advanced HCC.

Optimizing the Selection of Frontline TKIs for Advanced HCC

November 24th 2021

Experts in gastroenterology share their approaches to first-line single-agent and combination TKI therapies for the treatment of advanced HCC.

Updates to First-line Treatment Options for Advanced HCC

November 17th 2021

Andrea Casadei Gardini, MD, presents the case of a 63-year-old man diagnosed with advanced HCC, and the panel reviews available first-line treatment options for patients with advanced HCC.

Is There a Role for Systemic Therapy for Patients With Intermediate HCC?

November 17th 2021

Gastroenterology experts discuss whether there a is a role for systemic therapy for the management of intermediate HCC.

Role of TACE and TARE in the Treatment of HCC

November 10th 2021

Andrea Casadei Gardini, MD, and Stephen L. Chan, MD, examine the use of TACE and TARE-Y90 for the treatment of HCC.

Updates to Adjuvant and Neoadjuvant Therapy in Early HCC

November 10th 2021

Stephen L. Chan, MD, reviews the case of a 72-year-old woman with mild alcoholic cirrhosis and provides insight on the potential role of adjuvant and neoadjuvant therapy for the treatment of HCC.